Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

Autor: Croop, Robert, Goadsby, Peter J, Stock, David A, Conway, Charles M, Forshaw, Micaela, Stock, Elyse G, Coric, Vladimir, Lipton, Richard B
Zdroj: In The Lancet 31 August-6 September 2019 394(10200):737-745
Databáze: ScienceDirect